Kinase Inhibitors

NX-2127 View larger

NX-2127

AT73463

CAS 2416131-46-7

More details

Molarity Calculation Cart®

HOW TO ORDER

$93.00

$93.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $41.85 Total: $4,185.00
150 $48.36 Total: $2,418.00
125 $56.73 Total: $1,418.25
110 $66.96 Total: $669.60
15 $79.05 Total: $395.25

Data sheet

Molecular FormulaC39H45N9O5
Molecular Weight719.83
CAS Numbers2416131-46-7
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeO=C1C=2C(C(=O)N1C3C(=O)NC(=O)CC3)=CC=C(C2)N4C[C@H](CN5CCC(CC5)C6=CC=C(NC=7C(C(N)=O)=NC=C(N7)N8CCCCC8)C=C6)CC4
ReferencesRobbins D W, et al. Nx-2127, a degrader of BTK and IMiD neosubstrates, for the treatment of B-cell malignancies. Blood, 2020, 136 34.

More info

NX-2127 (ETX2514 Triethylamine) is an orally active BTK inhibitor that induces degradation of mutant BTKC481S in cells.NX-2127 has potent antiproliferative activity and inhibits the proliferation of BTKC481S mutant TMD8 cells.NX-2127 potently catalyzes the degradation of Ikaros (IKZF1) and Aiolos (IKZF3) at 25 nM and 54 nM, respectively. NX-2127 is associated with the immune system, stimulating T cell activation and increasing IL-2 production in primary human T cells.